Literature DB >> 21778897

Increased incidence of eosinophilic esophagitis in children and adults with celiac disease.

Jennifer S Thompson1, Benjamin Lebwohl, Norelle Rizkalla Reilly, Nicholas J Talley, Govind Bhagat, Peter H R Green.   

Abstract

GOALS AND
BACKGROUND: Case series have suggested an association between eosinophilic esophagitis (EoE) and celiac disease (CD) in children. We analyzed a cohort of patients with CD to confirm this association in children, and determine whether it extends into adulthood.
METHODS: A database of patients with CD was reviewed to determine the number of patients with comorbid diagnoses of EoE. Histopathology reports of esophageal biopsies were reviewed to identify all cases of increased esophageal eosinophilia. Cases of EoE were diagnosed if biopsies revealed ≥ 15 eosinophils per high power field and associated symptoms were present. Age-adjusted and sex-adjusted standardized incidence ratios (SIR) with corresponding 95% confidence intervals (CI) were calculated in comparison to published US population-derived incidence data.
RESULTS: EoE was diagnosed in 4 children and 10 adults. EoE is more common compared with the general population; SIR for children was 35.6 (95% CI, 9.3-79.0) and for adults 13.1 (95% CI, 6.2-22.5). Overall, the age-adjusted and sex-adjusted SIR was 16.0 (95% CI, 8.7-25.5).
CONCLUSIONS: The incidence of EoE in our cohort of patients with CD was increased compared with the general population. Coexistent EoE should be considered in patients with CD who have persistent esophageal symptoms.

Entities:  

Mesh:

Year:  2012        PMID: 21778897     DOI: 10.1097/MCG.0b013e318221aefd

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  17 in total

Review 1.  Epidemiology and Natural History of Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Ikuo Hirano
Journal:  Gastroenterology       Date:  2017-08-01       Impact factor: 22.682

2.  Increased Risk of Esophageal Eosinophilia and Eosinophilic Esophagitis in Patients With Active Celiac Disease on Biopsy.

Authors:  Elizabeth T Jensen; Swathi Eluri; Benjamin Lebwohl; Robert M Genta; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-02-24       Impact factor: 11.382

Review 3.  Eosinophilic esophagitis phenotypes: Ready for prime time?

Authors:  Dan Atkins; Glenn T Furuta; Chris A Liacouras; Jonathan M Spergel
Journal:  Pediatr Allergy Immunol       Date:  2017-05-04       Impact factor: 6.377

Review 4.  Eosinophilic esophagitis: current treatment.

Authors:  Matthew Redd; Ron Schey
Journal:  Dig Dis Sci       Date:  2012-09-22       Impact factor: 3.199

5.  Eosinophilic oesophagitis and coeliac disease: is there an association?

Authors:  Ana Margarida Vaz; Antonio Jesus Cadilla; Diamantino Sousa; Horácio Guerreiro
Journal:  BMJ Case Rep       Date:  2017-11-09

6.  Emerging therapeutic options for eosinophilic esophagitis.

Authors:  Timothy Dougherty; Sindu Stephen; Marie L Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-02

7.  Eosinophilic oesophagitis in children: an uncommon occurrence in a predominantly Chinese population in Singapore.

Authors:  Li Nien Michelle Tan; Supriya Srivastava; Ming Teh; Seng Hock Quak; Marion M Aw
Journal:  Singapore Med J       Date:  2016-03-15       Impact factor: 1.858

8.  Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study.

Authors:  Jonas F Ludvigsson; Pertti Aro; Marjorie M Walker; Michael Vieth; Lars Agréus; Nicholas J Talley; Joseph A Murray; Jukka Ronkainen
Journal:  Scand J Gastroenterol       Date:  2013-05-14       Impact factor: 2.423

9.  Coeliac disease in children in Christchurch, New Zealand: Presentation and patterns from 2000-2010.

Authors:  Adeline Kho; Martin Whitehead; Andrew S Day
Journal:  World J Clin Pediatr       Date:  2015-11-08

Review 10.  Coeliac disease: to biopsy or not?

Authors:  Norelle R Reilly; Steffen Husby; David S Sanders; Peter H R Green
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-10-11       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.